Skip to main content

Peer Review reports

From: Comprehensive pan-cancer analysis of CHRDL1 and experimental validation of its role in lung adenocarcinoma

Original Submission
24 Nov 2024 Submitted Original manuscript
2 Dec 2024 Author responded Author comments - Min Jiang
3 Dec 2024 Author responded Author comments - Min Jiang
Resubmission - Version 2
2 Dec 2024 Submitted Manuscript version 2
11 Dec 2024 Author responded Author comments - Min Jiang
Resubmission - Version 3
11 Dec 2024 Submitted Manuscript version 3
1 Jan 2025 Reviewed Reviewer Report
23 Mar 2025 Reviewed Reviewer Report
1 Apr 2025 Author responded Author comments - Min Jiang
Resubmission - Version 4
1 Apr 2025 Submitted Manuscript version 4
9 Apr 2025 Reviewed Reviewer Report
11 Apr 2025 Reviewed Reviewer Report
15 Apr 2025 Author responded Author comments - Min Jiang
Resubmission - Version 5
15 Apr 2025 Submitted Manuscript version 5
Publishing
16 Apr 2025 Editorially accepted
26 Apr 2025 Article published 10.1186/s12885-025-14174-0

You can find further information about peer review here.

Back to article page